References
- Sullivan KM, Storb R, Buckner CD, et al. Graft-versus-host disease as
adoptive immunotherapy in patients with advanced hematologic
neoplasms. N Engl J Med 1989;320(13):828-834.
- Eibl B, Schwaighofer H, Nachbaur D, et al. Evidence for a
graft-versus-tumor effect in a patient treated with marrow ablative
chemotherapy and allogeneic bone marrow transplantation for breast
cancer. Blood 1996;88(4):1501-1508.
- Childs R, Chernoff A, Contentin N, et al. Regression of metastatic
renal-cell carcinoma after nonmyeloablative allogeneic
peripheral-blood stem-cell transplantation. N Engl J Med
2000;343(11):750-758.
- J.H.F Falkenburg, I. Jedema Allo-reactive T cells for the treatment of
hematological malignancies. Mol Oncol 2015;9(10):1894-903.
- Shanis D, Anandi P, Grant C, et al. Risks factors and timing of
genital human papillomavirus (HPV) infection in female stem cell
transplant survivors: a longitudinal study. Bone Marrow Transplant
2018;53(1):78-83.
- Bipin N, Pamela S, Aarthi S, et al. Increased risk of cervical
dysplasia in long-term survivors of allogeneic stem cell
transplantation-implications for screening and HPV vaccination. Biol
Blood Marrow Transplant 2008;14(9):1072-1075.